| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adenovirus vectors as recombinant viral vaccines
|
Imler, Jean-Luc
|
|
1995
|
13 |
13 |
p. 1143-1151
9 p.
|
article
|
| 2 |
A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies
|
Scodeller, Eduardo A.
|
|
1995
|
13 |
13 |
p. 1233-1239
7 p.
|
article
|
| 3 |
An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system
|
Perrin, Pierre
|
|
1995
|
13 |
13 |
p. 1244-1250
7 p.
|
article
|
| 4 |
Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry
|
Miller, E.
|
|
1995
|
13 |
13 |
p. 1183-1186
4 p.
|
article
|
| 5 |
Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories
|
Hulskotte, Ellen G.J.
|
|
1995
|
13 |
13 |
p. 1187-1197
11 p.
|
article
|
| 6 |
Calendar
|
|
|
1995
|
13 |
13 |
p. 1260-
1 p.
|
article
|
| 7 |
Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field
|
Da Villa, G.
|
|
1995
|
13 |
13 |
p. 1240-1243
4 p.
|
article
|
| 8 |
Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential
|
Gorringe, Andrew R.
|
|
1995
|
13 |
13 |
p. 1207-1212
6 p.
|
article
|
| 9 |
Immune inducing polypeptide against Leucocytozoon protozoa; Leucocytozoon caulleryi recombinant vaccine construction for fowl protection against leucocytozoonosis
|
|
|
1995
|
13 |
13 |
p. 1259-
1 p.
|
article
|
| 10 |
Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines
|
Ward, Richard L.
|
|
1995
|
13 |
13 |
p. 1226-1232
7 p.
|
article
|
| 11 |
Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies
|
Ploton, Isabelle N.
|
|
1995
|
13 |
13 |
p. 1161-1169
9 p.
|
article
|
| 12 |
Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection
|
Srivastava, Ashok Kumar
|
|
1995
|
13 |
13 |
p. 1251-1258
8 p.
|
article
|
| 13 |
Neisseria gonorrhoeae IgA1 proteases share epitopes recognized by neutralizing antibodies
|
Lomholt, Hans
|
|
1995
|
13 |
13 |
p. 1213-1219
7 p.
|
article
|
| 14 |
New differentially expressed Leishmania genes and proteins; Leishmania donovani attenuation by virulence protein deletion, and recombinant vaccine and diagnostic DNA probe production
|
|
|
1995
|
13 |
13 |
p. 1259-
1 p.
|
article
|
| 15 |
New recombinant, non-glycosylated MHC polypeptide; major histocompatibility complex expression in Escherichia coli for multiple sclerosis, rheumatoid arthritis and myasthenia gravis autoantigen recombinant vaccine preparation
|
|
|
1995
|
13 |
13 |
p. 1259-
1 p.
|
article
|
| 16 |
Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein
|
Gorse, Geoffrey J.
|
|
1995
|
13 |
13 |
p. 1170-1179
10 p.
|
article
|
| 17 |
Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia
|
Fulop, Mark
|
|
1995
|
13 |
13 |
p. 1220-1225
6 p.
|
article
|
| 18 |
The effect of temperature on the stability of the synthetic SPf(66)n malaria vaccine
|
López, M.C.
|
|
1995
|
13 |
13 |
p. 1180-1182
3 p.
|
article
|
| 19 |
Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial
|
Boulter, Nicky R.
|
|
1995
|
13 |
13 |
p. 1152-1160
9 p.
|
article
|
| 20 |
The use of synthetic peptides can be a misleading approach to generate vaccines against scorpion toxins
|
Calderon-Aranda, Emma Soraida
|
|
1995
|
13 |
13 |
p. 1198-1206
9 p.
|
article
|
| 21 |
Vector for expressing viral protein in muscle cells; hepatitis B virus vector e.g. plasmid pCMV-HBS, plasmid pRSV-HBS and plasmid pHBV-S1.S2.S, for application as an HIV virus infection intramuscular recombinant vaccine
|
|
|
1995
|
13 |
13 |
p. 1259-
1 p.
|
article
|
Journal description